IOVA·462260100·US·equity·Healthcare - Biotechnology-13D/G
IOVA (IOVANCE BIOTHERAPEUTICS INC) is held by 136 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($109.1M), STATE STREET CORP ($61.2M), TWO SIGMA INVESTMENTS, LP ($48M). Net institutional sentiment: Bullish.
See how IOVA's score breaks down across 4 SEC sources
Showing 1-20 of 149
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer